Intrexon Raises $66.9M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Intrexon has raised $66.9 million, according to a document filed with the US Securities and Exchange Commission last week.

Based in Blacksburg, Va., the genetic engineering firm did not say how the funds will be used but said the offering was not made in connection with a business combination transaction such as a merger.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.